Sign in
Taking peopleNo phase

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Key facts

Who runs it
Canadian Cancer Trials Group
Where
Canada and New Zealand12 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
249 people, planned
Started
10 Dec 2024
Expected to end
30 Nov 2031
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Surgery
  • Active Surveillance
Record updated
11 August 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Histologically confirmed diagnosis of vulvar squamous cell carcinoma (VSCC)
  • Surgically staged FIGO I-II VSCC as per FIGO 2021 guidelines
  • Vulvar resection according to standard of care guidelines
  • Post-operative margin assessment of tumour clearance, dVIN and p53 status
  • Participants' age must be ≥ 18 years old
  • Participant is able (i.e. sufficiently fluent) and willing to complete the quality of life and/or health utility questionnaires in either English or French
  • Participant's consent must be appropriately obtained in accordance with applicable local and regulatory requirements

Who cannot take part

  • Participants referred for/receiving/or previously received adjuvant vulvar radiation or chemotherapy
  • Surgical margins positive for invasive cancer
  • Participants with a history of other malignancies, except: adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumours curatively treated with no evidence of disease for ≥ 5 years
  • Recurrent vulvar squamous cell carcinoma
  • Non-squamous cell carcinoma histotypes
  • Primary tumour HPV-I p53 wild-type VSCC
  • Lymph node positive VSCC or lymph nodes with isolated tumour cells

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?

The 3 groups in the trial

  • Sub-Study A: Active SurveillanceExisting treatment, for comparison

    If the laboratory test results show vulvar cancer is caused by HPV

    Treatment: Active Surveillance

  • Sub-Study B: Re-excisionExisting treatment, for comparison

    If the laboratory test results show vulvar cancer is not caused by HPV

    Treatment: Surgery

  • Sub-Study B: Active SurveillanceExisting treatment, for comparison

    If the laboratory test results show vulvar cancer is not caused by HPV

    Treatment: Active Surveillance

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
Record updated
11 August 2026